CBU
HAE icon

CIBC Bancorp USA’s Haemonetics HAE Stock Holding History

CIBC Bancorp USA’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$260K Buy
+3,469
New +$223K ﹤0.01% 1628
2025
Q3 		$251K Buy
+5,140
New +$318K ﹤0.01% 1161

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CIBC Bancorp USA's HAE Position: Q2 2026 in Review

CIBC Bancorp USA opened a new position in Haemonetics (HAE) in Q2 2026: 3,469 shares worth $260K. The stake represents ﹤0.01% of the portfolio and ranks #1628 among its holdings. This is a return to the name: CIBC Bancorp USA previously reported a position in HAE as recently as Q3 2025.

CIBC Bancorp USA first reported a position in HAE in Q3 2025 and has held it in 2 quarters since. 330 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • CIBC Bancorp USA held 3,469 shares of Haemonetics worth $260K as of Q2 2026.
  • Haemonetics was a new CIBC Bancorp USA position in Q2 2026.
  • Haemonetics made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q2 2026, its #1628 holding.
  • CIBC Bancorp USA first reported a position in Haemonetics in Q3 2025 and has held it in 2 quarters since.
  • 330 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.